Aurobindo Pharma Limited (AUROPHARMA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.082x

Based on the latest financial reports, Aurobindo Pharma Limited (AUROPHARMA) has a cash flow conversion efficiency ratio of 0.082x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs28.85 Billion ≈ $312.01 Million USD) by net assets (Rs350.34 Billion ≈ $3.79 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Aurobindo Pharma Limited balance sheet independence to measure how much of total assets are equity-financed.

Aurobindo Pharma Limited - Cash Flow Conversion Efficiency Trend (2004–2026)

This chart illustrates how Aurobindo Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Aurobindo Pharma Limited to evaluate the quality of earnings relative to operating cash generation.

Aurobindo Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aurobindo Pharma Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhengzhou Yutong Bus Co Ltd SHG:600066	0.005x
Shandong Sinocera Func Material SHE:300285	0.037x
Anglo American Platinum Ltd JSE:AMS	0.160x
SailPoint, Inc. Common Stock NASDAQ:SAIL	0.009x
Modine Manufacturing Company NYSE:MOD	0.022x
Cytokinetics Inc NASDAQ:CYTK	0.176x
Accor S. A. PA:AC	0.123x
Symrise AG F:SY1	0.019x

Annual Cash Flow Conversion Efficiency for Aurobindo Pharma Limited (2004–2026)

The table below shows the annual cash flow conversion efficiency of Aurobindo Pharma Limited from 2004 to 2026. For the full company profile with market capitalisation and key ratios, see market value of Aurobindo Pharma Limited.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs378.83 Billion ≈ $4.10 Billion	Rs55.13 Billion ≈ $596.22 Million	0.146x	+21.06%
2025-03-31	Rs326.47 Billion ≈ $3.53 Billion	Rs39.25 Billion ≈ $424.43 Million	0.120x	+47.40%
2024-03-31	Rs298.51 Billion ≈ $3.23 Billion	Rs24.35 Billion ≈ $263.28 Million	0.082x	-8.25%
2023-03-31	Rs268.52 Billion ≈ $2.90 Billion	Rs23.87 Billion ≈ $258.12 Million	0.089x	-56.46%
2022-03-31	Rs245.74 Billion ≈ $2.66 Billion	Rs50.16 Billion ≈ $542.51 Million	0.204x	+34.47%
2021-03-31	Rs219.29 Billion ≈ $2.37 Billion	Rs33.29 Billion ≈ $360.01 Million	0.152x	-41.70%
2020-03-31	Rs168.25 Billion ≈ $1.82 Billion	Rs43.81 Billion ≈ $473.82 Million	0.260x	+119.12%
2019-03-31	Rs138.92 Billion ≈ $1.50 Billion	Rs16.51 Billion ≈ $178.55 Million	0.119x	-28.97%
2018-03-31	Rs116.82 Billion ≈ $1.26 Billion	Rs19.55 Billion ≈ $211.37 Million	0.167x	-52.16%
2017-03-31	Rs93.74 Billion ≈ $1.01 Billion	Rs32.79 Billion ≈ $354.57 Million	0.350x	+67.95%
2016-03-31	Rs68.18 Billion ≈ $737.31 Million	Rs14.20 Billion ≈ $153.54 Million	0.208x	-12.75%
2015-03-31	Rs51.82 Billion ≈ $560.38 Million	Rs12.37 Billion ≈ $133.76 Million	0.239x	+39.45%
2014-03-31	Rs37.76 Billion ≈ $408.34 Million	Rs6.46 Billion ≈ $69.89 Million	0.171x	+63.26%
2013-03-31	Rs26.22 Billion ≈ $283.53 Million	Rs2.75 Billion ≈ $29.73 Million	0.105x	-24.48%
2012-03-31	Rs23.50 Billion ≈ $254.13 Million	Rs3.26 Billion ≈ $35.28 Million	0.139x	+1.45%
2011-03-31	Rs24.49 Billion ≈ $264.85 Million	Rs3.35 Billion ≈ $36.24 Million	0.137x	-41.49%
2010-03-31	Rs18.33 Billion ≈ $198.28 Million	Rs4.29 Billion ≈ $46.37 Million	0.234x	+113.93%
2009-03-31	Rs12.44 Billion ≈ $134.58 Million	Rs1.36 Billion ≈ $14.71 Million	0.109x	-22.37%
2008-03-31	Rs11.27 Billion ≈ $121.91 Million	Rs1.59 Billion ≈ $17.16 Million	0.141x	+571.59%
2007-03-31	Rs8.90 Billion ≈ $96.20 Million	Rs186.50 Million ≈ $2.02 Million	0.021x	+289.34%
2006-03-31	Rs8.17 Billion ≈ $88.39 Million	Rs-90.50 Million ≈ $-978.72K	-0.011x	-106.48%
2005-03-31	Rs7.14 Billion ≈ $77.27 Million	Rs1.22 Billion ≈ $13.20 Million	0.171x	+522.70%
2004-03-31	Rs7.25 Billion ≈ $78.40 Million	Rs198.90 Million ≈ $2.15 Million	0.027x	--

About Aurobindo Pharma Limited

NSE:AUROPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$10.32 Billion

Rs953.98 Billion INR

Market Cap Rank

#2210 Global

#93 in India

Share Price

Rs1658.00

Change (1 day)

+4.35%

52-Week Range

Rs1022.20 - Rs1658.00

All Time High

Rs1658.00